Infectious diseases of humans: Dynamics and control
暂无分享,去创建一个
[1] C. Benoist,et al. Following a diabetogenic T cell from genesis through pathogenesis , 1993, Cell.
[2] H. von Boehmer,et al. CD4+8− help prevents rapid deletion of CD8+ cells after a transient response to antigen , 1993, European journal of immunology.
[3] D. McConkey,et al. Killing of immature CD4+CD8+ thymocytes in vivo by anti‐CD3 or 5′‐(N‐ethyl)‐carboxamido‐adenosine is blocked by glucocorticoid receptor antagonist RU‐486 , 1993, European journal of immunology.
[4] H. Macdonald,et al. Peripheral T cell activation and deletion induced by transfer of lymphocyte subsets expressing endogenous or exogenous mouse mammary tumor virus , 1993, The Journal of experimental medicine.
[5] G. Kroemer,et al. Glucocorticoid-mediated control of the activation and clonal deletion of peripheral T cells in vivo , 1993, The Journal of experimental medicine.
[6] B. Rocha,et al. Clonal anergy blocks in vivo growth of mature T cells and can be reversed in the absence of antigen , 1993, The Journal of experimental medicine.
[7] J. Todd,et al. Linkage on chromosome 3 of autoimmune diabetes and defective Fc receptor for IgG in NOD mice. , 1993, Science.
[8] P. Franchimont,et al. Thymic neurohypophysial-related peptides and T cell selection , 1993, Regulatory Peptides.
[9] S. Orrenius,et al. Cyclic AMP potentiates glucocorticoid‐induced endogenous endonuclease activation in thymocytes 1 , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[10] V. Geenen,et al. Evidence that insulin-like growth factor 2 (IGF2) is the dominant thymic peptide of the insulin superfamily. , 1993, Thymus.
[11] J. Seidman,et al. Progression to diabetes in nonobese diabetic (NOD) mice with transgenic T cell receptors. , 1993, Science.
[12] J. Swinton,et al. Dynamic interaction between Leishmania infection in mice and Th1‐type CD4+ T‐cells: complexity in outcome without a requirement for Th2‐type responses , 1993, Parasite immunology.
[13] S. Cobbold,et al. Reprogramming the Immune System for Peripheral Tolerance with CD4 and CD8 Monoclonal Antibodies , 1992, Immunological reviews.